Emm is a technology company.
Emm has raised $9.0M across 1 funding round.
Emm has raised $9.0M in total across 1 funding round.
Emm has raised $9.0M in total across 1 funding round.
Emm's investors include Lunar Ventures, Vivek Garipalli.
Emm is a UK-based femtech company developing the world's first smart menstrual cup embedded with advanced biosensors to provide deep, personalized insights into menstrual and reproductive health. Its product combines a medical-grade silicone menstrual cup with ultra-thin sensors and a connected mobile app that tracks menstrual flow, cycle patterns, and duration, empowering users with actionable data and greater autonomy over their health. Emm targets people who menstruate, addressing a significant gap in women’s health technology by offering a data-driven, privacy-first solution. The company has raised over $9 million in funding and plans a UK launch in early 2026, with international expansion to follow[1][2][3][6].
Founded in 2020 by CEO Jenny Button, who was inspired during the COVID lockdown after noticing the lack of reproductive health data in wearable tech like Oura and Whoop rings, Emm has spent five years iterating its design with engineers and clinical experts. Button’s vision was to create a wearable device that could track menstrual health with the same precision as other health metrics, aiming to transform diagnosis and treatment of reproductive conditions such as endometriosis. Early traction includes securing 30,000 pre-orders and closing a $9 million seed round led by Lunar Ventures, Alumni Ventures, and BlueLion Global[1][2][3].
Emm rides the growing trend of femtech innovation and the increasing demand for personalized health data. Menstrual health has historically been underfunded and under-researched despite affecting half the global population. Emm’s timing is critical as wearables and biowearables become mainstream, and consumers seek more comprehensive health insights beyond fitness and sleep. By pioneering smart menstrual care, Emm is poised to influence the broader ecosystem by setting new standards for menstrual health monitoring, potentially accelerating diagnosis and treatment of reproductive health issues and expanding femtech’s role in healthcare[1][2][3].
Emm’s near-term focus is the 2026 UK launch followed by international expansion, including entry into the U.S. market by early 2027. Future developments may include expanding beyond menstrual tracking into diagnostics, digital care tools, and therapeutics for broader women’s health conditions. As awareness and investment in femtech grow, Emm’s data-driven approach and innovative hardware position it to become a leader in transforming reproductive health management. The company’s mission to empower users with data to advocate for their health aligns with wider trends toward personalized, preventive healthcare and digital health empowerment[1][2].
In summary, Emm is not just launching a product; it is creating a new category of smart menstrual care that could redefine how menstrual health is understood and managed globally.
Emm has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Seed in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2025 | $9.0M Seed | Lunar Ventures, Vivek Garipalli |